What is Stokes Pharmacy?
Established in 1975, Stokes Pharmacy has evolved into a critical player in the pharmaceutical compounding industry. The company distinguishes itself through a dual-focus model, providing high-quality, customized medication solutions for human patients and veterinary practices alike. Their product portfolio, which includes specialized treatments for feline infectious peritonitis and equine health, reflects a deep technical expertise in formulation science. By maintaining rigorous quality control standards and prioritizing patient outcomes, Stokes Pharmacy has built a reputation for reliability and precision in a sector where safety is paramount. Their operational framework is designed to meet the complex needs of modern healthcare providers, ensuring that every prescription is handled with the highest level of clinical oversight and logistical efficiency.
How much funding has Stokes Pharmacy raised?
Stokes Pharmacy has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Stokes Pharmacy
PPP
Public-Private Partnership
What's next for Stokes Pharmacy?
With the recent influx of capital, Stokes Pharmacy is positioned to accelerate its enterprise-level growth strategy. The focus will likely shift toward expanding its manufacturing capacity and integrating advanced digital health solutions to streamline the prescription fulfillment process. As the demand for personalized medicine continues to rise, the company is well-positioned to capture additional market share by scaling its veterinary and human health divisions. Future initiatives will likely prioritize the optimization of supply chain resilience and the continued adoption of cutting-edge compounding technologies to maintain its competitive edge in the pharmaceutical landscape.
See full Stokes Pharmacy company page
